British journal of haematology
Combining an immunomodulatory drug with a TPO-RA to treat multirefractory ITP patients: The Spanish ITP Group experience.
María-Eva Mingot-Castellano, Patricia Alcalde-Mellado, Laura Entrena-Ureña, Cristina Pascual-Izquierdo, Denis Zafra-Torres, Mariana Canaro Hirnyk, José-María Bastida, Silvia Bernat-Pablo, Daniel Martínez-Carballeira, Isabel-Socorro Caparrós-Miranda, Amalia Cuesta-García, Sunil Lakhwani, Blanca Sánchez-González, Marta Canet-Maldonado, María-Del-Carmen Gómez-Del-Castillo-Solano
Published: 202610.1111/bjh.70306
Abstract
Multirefractory immune thrombocytopenia (ITP) is difficult to manage. The simultaneous administration of an immunosuppressive/immunomodulatory drug (IS/IM) and a thrombopoietin receptor agonist (TPO-RA) is increasingly used. We present the experience…
Preview only. Read the full abstract at the source